Articles published by Forte Biosciences, Inc.
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update
August 14, 2024
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
May 13, 2024
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update
November 13, 2023
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update
August 14, 2023
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update
May 15, 2023
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update
March 31, 2023
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Mr. David Gryska Appointed to Forte Biosciences Board of Directors
January 12, 2023
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
November 14, 2022
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors
November 14, 2022
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update
August 15, 2022
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update
May 16, 2022
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance
September 02, 2021
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
FBRX
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.